OncoMed Pharmaceuticals, Inc (OMED) - NASDAQ
From other sites
Company Description
OncoMed Pharmaceuticals, Inc. is a clinical development-stage biotechnology company that discovers and develops first-in-class protein therapeutics targeting cancer stem cells. The company has established a library of antibodies to cancer stem cell proteins for the treatment of solid tumors such... More
Sector: Healthcare
Industry: Biotechnology
Country: United States